ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 254 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2022. The put-call ratio across all filers is 8.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $142 | -51.2% | 11,286 | -31.8% | 0.00% | -75.0% |
| Q4 2022 | $291 | -100.0% | 16,550 | -97.2% | 0.00% | -95.8% |
| Q3 2022 | $8,859,000 | +127.2% | 581,743 | +121.2% | 0.10% | +123.3% |
| Q2 2022 | $3,900,000 | +432.1% | 262,985 | +707.6% | 0.04% | +760.0% |
| Q1 2022 | $733,000 | -84.5% | 32,563 | -90.8% | 0.01% | -82.8% |
| Q3 2021 | $4,731,000 | +385.2% | 353,921 | +571.8% | 0.03% | +222.2% |
| Q2 2021 | $975,000 | -65.9% | 52,685 | -72.3% | 0.01% | -69.0% |
| Q1 2021 | $2,859,000 | +168.7% | 190,449 | +158.4% | 0.03% | +38.1% |
| Q4 2020 | $1,064,000 | +101.5% | 73,693 | +13.5% | 0.02% | +40.0% |
| Q3 2020 | $528,000 | -6.5% | 64,947 | +12.8% | 0.02% | -37.5% |
| Q4 2019 | $565,000 | +448.5% | 57,599 | +433.0% | 0.02% | +50.0% |
| Q1 2019 | $103,000 | – | 10,807 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |